Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06378229 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Psilocybin for Hospitalized Patients with Treatment-resistant Depression

Study acronym: PSIHOS-D
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 19, 2024 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Site contact updatedv5
  2. Start date changed from estimate of May 2024 to May 21, 2024v4
  3. Start date: Apr 2024 to May 2024v3
  4. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to determine the safety and feasibility of performing psilocybin-assisted psychotherapy in patients hospitalized for treatment-resistant depression.
Trial Details
NCT Number NCT06378229
Lead Sponsor University Hospital, Ghent
Collaborators: Filament Health Corp.
Conditions
(from sponsor)		 Treatment Resistant Depression
Related terms Depressive Disorder, Treatment-Resistant
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov